Artal Group S.A. - COLUCID PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of COLUCID PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$203,000
-90.4%
5,575
-90.0%
0.01%
-88.1%
Q3 2016$2,121,000
+4510.9%
55,575
+896.9%
0.04%
+4100.0%
Q2 2016$46,000
+31.4%
5,5750.0%0.00%0.0%
Q1 2016$35,000
-25.5%
5,5750.0%0.00%0.0%
Q4 2015$47,000
+113.6%
5,5750.0%0.00%
Q3 2015$22,000
-56.0%
5,5750.0%0.00%
-100.0%
Q2 2015$50,0005,5750.00%
Other shareholders
COLUCID PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 3,056,563$11,829,0001.22%
SPHERA FUNDS MANAGEMENT LTD. 317,250$1,228,0000.16%
PIPER SANDLER & CO. 5,215$20,0000.02%
Pentwater Capital Management LP 483,686$1,872,0000.02%
MPM ASSET MANAGEMENT LLC 21,806$84,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 100,794$390,000,0000.01%
VANGUARD GROUP INC 4,540,091$161,209,0000.01%
Tower Research Capital LLC (TRC) 11,555$45,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 1,355,835$5,247,0000.00%
PANAGORA ASSET MANAGEMENT INC 31,891$123,0000.00%
View complete list of COLUCID PHARMACEUTICALS INC shareholders